Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

The modular, scalable monitoring platform offers a range of physiological measurements, including Masimo SET ® pulse oximetry ... innovative measurements, sensors, patient monitors, and ...

The modular, scalable monitoring platform offers a range of physiological measurements, including Masimo SET ® pulse oximetry, measure-on-inflation noninvasive blood pressure, continuous ...

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's smartwatches infringe two of its design patents as part of a broader intellectual property ...

It was really about the O2 sensor patent infringement case Masimo brought against Apple. In theory, that’s a completely unrelated case. In practice, not so much. If you need a quick recap ...

This is the latest development in the long legal battle between Masimo, a medical tech firm, and Apple in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the ...